Development of a Valid Test Battery for Assessing Driving Ability When Influenced by Drugs.
NCT00967421 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2017-10-02
Summary
The purpose of the validation study is to develop a valid test battery for assessing driving ability in a driving simulator when influenced by drugs. Ethanol has known, well-documented and well-characterized effects on driving behaviour and accident risk, and will be used to assess the simulator test scenarios' sensitivity to drug effects. Once the test scenarios have been refined and their ability to predict driving accident risk have been validated, we plan to use the simulator to assess driving ability under the influence of different drugs suspected to produce driving impairment.
Conditions
- Automobile Driving
Interventions
- DRUG
-
ethanol
BAC level 0.5 g/dL (drink + placebo pill). Drink with 2,4 grams per kilo body weight, administered orally during 60 min, administration ending 30 min prior to start of testing. Placebo pill.
- DRUG
-
Ethanol
BAC level 1.0 g/dL (drink + placebo pill). Drink with 3,6 grams per kilo body weight, administered orally during 60 min, administration ending 30 min prior to start of testing. Placebo pill.
- OTHER
-
Placebo drink
Placebo drink containing no alcohol + placebo pill
Sponsors & Collaborators
-
SINTEF Health Research
collaborator OTHER -
Norwegian University of Science and Technology
collaborator OTHER -
Norwegian Institute of Public Health
collaborator OTHER_GOV -
St. Olavs Hospital
lead OTHER
Principal Investigators
-
Lars Slørdal, PhD, MD · Norwegian University of Science and Technology
-
Gunnar D Jenssen · SINTEF Health Research
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 25 Years
- Max Age
- 50 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-09-30
- Primary Completion
- 2009-11-30
- Completion
- 2010-11-30
Countries
- Norway
Study Locations
More Related Trials
-
Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition
NCT02404688 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Calibration and Validation of the STISIM Driving Simulator
NCT00720551 ·Status: COMPLETED ·Phase: NA
-
MedDrive's Responsiveness to Alcohol
NCT01781273 ·Status: COMPLETED ·Phase: NA
-
Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study I
NCT02709954 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Behavior Brain Responses
NCT03964350 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Sensory Stimulation During Simulated Driving
NCT03726840 ·Status: COMPLETED ·Phase: NA
-
A Study to Investigate the Drug-drug Interactions Between ACT-541468 and Ethanol in Healthy Subjects
NCT03609775 ·Status: COMPLETED ·Phase: PHASE1
-
Validation of the Drug Impaired Driving Scenario (DIDS) on the CRCDS-miniSim
NCT04970342 ·Status: COMPLETED ·Phase: PHASE1
-
Differential Acute Tolerance Development to Effects of Nitrous Oxide - 7
NCT00000255 ·Status: COMPLETED ·Phase: PHASE2
-
Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4
NCT00000252 ·Status: COMPLETED ·Phase: PHASE2
-
Role of Instructions in Nitrous Oxide Effects and Choice - 10
NCT00000258 ·Status: COMPLETED ·Phase: NA
-
Study of the Relationship Between Dose-concentration-effect of Delta-9-tetrahydrocannabinol (THC) and the Ability to Drive in Chronic or Occasional Cannabis Users
NCT02061020 ·Status: COMPLETED ·Phase: NA
-
Whole Blood-plasma-oral Fluid Ratios of Psychoactive Drugs and Medicines
NCT00650130 ·Status: COMPLETED
-
Marijuana Drug Discrimination and Self-Administration
NCT00943930 ·Status: COMPLETED
-
Study of the Opioid Modulation of the Effect of Alcohol on the Dopaminergic Reward System
NCT03854942 ·Status: TERMINATED ·Phase: PHASE1
-
Divided Drug Delivery
NCT02869724 ·Status: UNKNOWN ·Phase: NA
-
Effects of Stimulants on Behavioral and Neural Markers of Social Motivation, Ability, and Neural Markers of Social Function
NCT05379959 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Cannabis Edibles and Simulated Driving
NCT06595576 ·Status: COMPLETED ·Phase: NA
-
Cannabioids as a New Intervention for Amphetamine Dependence
NCT02952196 ·Status: WITHDRAWN ·Phase: PHASE2
-
Safety and Tolerability of DMT in Healthy Adults
NCT05901012 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Different Modes of (S) Ketamine Administration in Healthy Participants
NCT03808259 ·Status: COMPLETED ·Phase: PHASE1
-
Registration of Tobacco, Coffee and Substance Use Among Acutely Admitted Psychiatric Patients
NCT00184184 ·Status: COMPLETED
-
Developing a Mobile Method to Measure THC-induced Impairment
NCT03804840 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Mephedrone and Alcohol Interactions in Humans
NCT02294266 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Stimulant Drugs on Social Perception
NCT03790618 ·Status: COMPLETED ·Phase: PHASE1